Life Sciences Tools and Services
Company Overview of InCube Labs, LLC
InCube Labs, LLC provides clinical research services. It provides services in various therapeutic areas, such as central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, gastrointestinal, end-stage renal disease, and cancer; drug delivery technologies, including transdermal, implantable, inhalation, intramuscular/subcutaneous, oral biotherapeutics, and inner ear; and medical devices comprising implantable and interventional devices, diagnostics, biomaterials and coatings, tissue engineering, and drug delivery. The company was incorporated in 2007 and is based in San Jose, California.
2051 Ringwood Avenue
San Jose, CA 95131
Founded in 2007
Key Executives for InCube Labs, LLC
Chairman and Chief Executive Officer
Vice President of Finance & Operations
Vice President of Business Development & Marketing
Vice President of ICL Texas
Vice President of Engineering
Compensation as of Fiscal Year 2014.
InCube Labs, LLC Key Developments
InCube Labs, LLC Launches Two New Life Sciences Companies in San Antonio
May 2 13
InCube Labs, LLC announced the launch of two new life sciences companies in San Antonio. Theracle and iBridge Medical join three existing InCube San Antonio companies, Corhythm, Neurolink and Fe3 Medical. Theracle is developing a combination therapy for the treatment of brain cancer known as gliomas, one of the most lethal forms of cancer. iBridge Medical is developing a technology platform for enhanced disease management of patients with active implanted medical devices. Gliomas represent a clear unmet medical need as approximately 50% of patients die within 18 months of a diagnosis, and current treatments are of limited effectiveness. iBridge Medical is developing a communications platform to enable information sharing between implanted devices and physicians, patients, hospitals and implant manufacturers, resulting in improved patient care. For example, iBridge's technology platform will enable physicians to monitor patient progress, incorporate appropriate information in their Electronic Health Record and give feedback to the patient as necessary.
InCube Labs Presents at The Seventh Annual SEMDA Conference, Feb-20-2013 08:30 AM
Feb 6 13
InCube Labs Presents at The Seventh Annual SEMDA Conference, Feb-20-2013 08:30 AM. Venue: Georgia Tech Global Learning Center, Atlanta, Georgia, United States. Speakers: Mir Imran, Chairman and CEO.
InCube Labs, LLC and Teijin Limited Announce Strategic Partnership to Accelerate Healthcare Innovation
Jan 8 13
InCube Labs, LLC announced that it has entered into a strategic partnership with Teijin Limited, a worldwide leader in technology innovation. Headquartered in Japan and with around 150 companies and 17,000 employees in over 20 countries worldwide, Teijin will have regular access to InCube Labs' leadership team to help define new strategic growth opportunities for Teijin's healthcare business. As part of the agreement, Teijin will also invest in InCube Ventures, InCube's life sciences venture fund. Through its strategic investment in InCube Ventures, Teijin will have access to InCube's network, portfolio companies and partners.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|